Angioedema Among Hypertensive Patients Treated with Aliskiren or Other Antihypertensive Medications in the United States

ConclusionsThe IR and risk of angioedema in patients with aliskiren monotherapy or FDC are comparable to BBs. The higher IR and risk of angioedema identified in the aliskiren FSC group may largely be driven by the concomitant use of ACEIs.
Source: American Journal of Cardiovascular Drugs - Category: Cardiology Source Type: research